MedTrace Logo

Data Collection Atrial Fibrillation Exploratory Study

NCT03647085 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2022-06-09

No results posted yet for this study

Summary

To characterize the impact of Atrial fibrillation (AFib) and Atrial Flutter (AFl) on signals measured using a wearable cardiac monitor prototype device.

To evaluate the relationship of AFib/AFl symptom severity with various physiologic signals measured from the wearable cardiac monitor prototype device.

Conditions

Interventions

DEVICE

Wearable cardiac monitor

Participants will be fitted with a wearable cardiac monitor placed on the skin that measures physiologic signals.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Bruce Johnson, PhD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-29
Primary Completion
2019-01-10
Completion
2019-01-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03647085 on ClinicalTrials.gov